PKN3 and prostate carcinoma: The shRNA knockdown of PKN3 in an orthotopic PC-3 prostate cancer model had a profound effect on primary tumor growth14, whereas an earlier report had demonstrated the relatively small effect on primary tumor growth using the same cancer cell line25.